Feng Xue

703 total citations
49 papers, 506 citations indexed

About

Feng Xue is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Feng Xue has authored 49 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 15 papers in Surgery and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Feng Xue's work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers) and Lung Cancer Treatments and Mutations (4 papers). Feng Xue is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers) and Lung Cancer Treatments and Mutations (4 papers). Feng Xue collaborates with scholars based in China, United States and Australia. Feng Xue's co-authors include Yanfu Sun, Ming Yang, Yanling Wang, Jialin Wang, Ning Dong, Yunlong Lei, Yiping Shen, Dong Wu, Kenli Li and Catherine J. Chu and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Feng Xue

45 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng Xue China 13 117 114 113 111 110 49 506
Yanjun Shi China 12 147 1.3× 104 0.9× 161 1.4× 47 0.4× 82 0.7× 26 507
Lukas Frick Switzerland 7 148 1.3× 59 0.5× 96 0.8× 73 0.7× 60 0.5× 11 339
Yadi Liao China 16 204 1.7× 137 1.2× 250 2.2× 126 1.1× 88 0.8× 21 582
Christian Dierkes Germany 12 71 0.6× 96 0.8× 150 1.3× 165 1.5× 76 0.7× 24 569
Joanne Chiu China 13 55 0.5× 53 0.5× 123 1.1× 241 2.2× 62 0.6× 52 516
Anand Rajan United States 14 38 0.3× 93 0.8× 228 2.0× 119 1.1× 64 0.6× 49 548
Howard Liu Australia 13 78 0.7× 71 0.6× 109 1.0× 202 1.8× 116 1.1× 43 555
Tamara Severi Belgium 9 287 2.5× 238 2.1× 198 1.8× 99 0.9× 96 0.9× 10 604
Shi Chang China 8 90 0.8× 100 0.9× 154 1.4× 63 0.6× 65 0.6× 20 434
Markus Benicke Germany 9 50 0.4× 42 0.4× 307 2.7× 180 1.6× 92 0.8× 10 510

Countries citing papers authored by Feng Xue

Since Specialization
Citations

This map shows the geographic impact of Feng Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Xue more than expected).

Fields of papers citing papers by Feng Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Xue. The network helps show where Feng Xue may publish in the future.

Co-authorship network of co-authors of Feng Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Xue. A scholar is included among the top collaborators of Feng Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Xue. Feng Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Wei, Lifang Chen, Qiang Lü, et al.. (2025). Sex disparity of liver cancer recurrence following surgery: sex-determining region Y gene promotes immunosuppressive microenvironment and favors metastasis. International Journal of Surgery. 111(11). 7666–7676.
2.
Xue, Feng, et al.. (2025). Targeting Dendritic Cells: An Emerging Agent in Dry Eye Disease Management. Ocular Immunology and Inflammation. 34(1). 155–165.
3.
Gao, Xiang, et al.. (2024). Modified Surgical Approach for Treating Zuska’s Disease: Complete Resection of the Sinus Tract and Duct. International Journal of Women s Health. Volume 16. 2003–2009.
4.
5.
Zhong, Weiying, Ming Liu, Feng Xue, et al.. (2022). Hemodynamic Characteristic Analysis of Aneurysm Wall Enhancement in Unruptured Middle Cerebral Artery Aneurysm. Frontiers in Neurology. 13. 781240–781240. 2 indexed citations
6.
Xue, Feng, Jian Zhai, Jianwei Liu, et al.. (2022). Efficacy and safety of second-line regorafenib after sorafenib or lenvatinib first line in patients with unresectable hepatocellular carcinoma: A real-world study.. Journal of Clinical Oncology. 40(16_suppl). e16125–e16125. 2 indexed citations
7.
Zhang, Xu‐Feng, Feng Xue, Jin He, et al.. (2021). Proposed modification of the eighth edition of the AJCC staging system for intrahepatic cholangiocarcinoma. HPB. 23(9). 1456–1466. 14 indexed citations
8.
Zhang, Xu‐Feng, Feng Xue, Fabio Bagante, et al.. (2021). Non-transplantable Recurrence After Resection for Transplantable Hepatocellular Carcinoma: Implication for Upfront Treatment Choice. Journal of Gastrointestinal Surgery. 26(5). 1021–1029. 5 indexed citations
9.
Tuo, Xiaoqian, Qing Wang, Lanbo Zhao, et al.. (2021). Near-Infrared Fluorescent Agent for In Vitro Screening of Endometrial Cancer and Precancerous Lesions. Frontiers in Oncology. 11. 713583–713583. 1 indexed citations
10.
Xue, Feng, Lixue Yang, Binghua Dai, et al.. (2020). Bioinformatics profiling identifies seven immune-related risk signatures for hepatocellular carcinoma. PeerJ. 8. e8301–e8301. 13 indexed citations
11.
Han, Lu, Sijia Ma, Lanbo Zhao, et al.. (2020). Clinical Evaluation of Li Brush Endometrial Samplers for Diagnosing Endometrial Lesions in Women With Intrauterine Devices. Frontiers in Medicine. 7. 598689–598689. 2 indexed citations
12.
Xue, Feng, Haiwei Wang, Yuanyuan Kong, et al.. (2020). Diagnosis of chronic stage of hypertensive retinopathy based on spectral domain optical coherence tomography. Journal of Clinical Hypertension. 22(7). 1247–1252. 5 indexed citations
13.
Xue, Feng, Luping Wang, Haiwei Wang, et al.. (2020). Branch retinal artery occlusion secondary to high-altitude exposure and diabetic retinopathy: a case report. BMC Ophthalmology. 20(1). 281–281. 1 indexed citations
14.
Tuo, Xiaoqian, Lanbo Zhao, Qi Wang, et al.. (2019). Validation of Molecular Typing for Endometrial Screening Test That Predicts Benign and Malignant Lesions. Frontiers in Oncology. 9. 561–561. 2 indexed citations
15.
Chen, Xing, et al.. (2017). Diffusion-weighted imaging of injuries to the visual centers of the brain in patients with type 2 diabetes and retinopathy. Experimental and Therapeutic Medicine. 14(2). 1153–1156. 6 indexed citations
16.
Yuan, Ke, Yunlong Lei, Hai‐Ning Chen, et al.. (2016). HBV-induced ROS accumulation promotes hepatocarcinogenesis through Snail-mediated epigenetic silencing of SOCS3. Cell Death and Differentiation. 23(4). 616–627. 84 indexed citations
17.
Hu, Lei, Feng Xue, Yunyun Li, et al.. (2014). A Long-Term Follow-Up and Comprehensive Observation of Risk and Prognosis Factors of Recurrence and Survival After Resection of Hepatocellular Carcinoma. Cell Biochemistry and Biophysics. 69(3). 421–431. 17 indexed citations
18.
Su, Jin, et al.. (2012). Efficacy and safety of erlotinib as first-line treatment in the elderly patients with advanced non-small cell lung cancer. Tumori. 32(2). 130–133. 1 indexed citations
19.
Xi, Tao, Eric C. H. Lai, Lehua Shi, et al.. (2012). Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: a non-randomized comparative study.. PubMed. 59(116). 1198–203. 26 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanjun Shi Breakdown of academic impact, for papers by Lukas Frick Breakdown of academic impact, for papers by Yadi Liao Breakdown of academic impact, for papers by Christian Dierkes Breakdown of academic impact, for papers by Joanne Chiu Breakdown of academic impact, for papers by Anand Rajan Breakdown of academic impact, for papers by Howard Liu Breakdown of academic impact, for papers by Tamara Severi Breakdown of academic impact, for papers by Shi Chang Breakdown of academic impact, for papers by Markus Benicke
Rankless by CCL
2026